Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials

Core Viewpoint - PetVivo Holdings, Inc. has entered into a Master Services Agreement with PiezoBioMembrane, Inc. to collaborate on the development of innovative functional biomaterials that can promote tissue and bone regeneration through piezoelectric stimulation [1][2]. Group 1: Partnership Structure and Strategic Benefits - The collaboration aims to combine PetVivo's extracellular matrix (ECM) biomaterial with PiezoBio's piezoelectric nanofibers to create a piezo-biomaterial that enhances healing and regeneration of damaged mammalian tissue and bone [2]. - PiezoBio's biodegradable piezoelectric nanomaterial acts as a battery-less electrical stimulator, providing a novel approach to tissue and bone regeneration [5]. Group 2: Product Development and Innovation - PetVivo has developed a biocompatible biomaterial that mimics mammalian tissue, which is crucial for minimizing adverse effects when implanted in animals or humans [3]. - The company's product SPRYNG® with OsteoCushion® Technology is an intra-articular injectable device that integrates with the animal's subsynovial tissue to restore joint mechanics and manage joint pain [4]. Group 3: Company Overview and Market Strategy - PetVivo focuses on manufacturing and commercializing innovative medical devices and therapeutics for companion animals, leveraging human therapies for efficient treatment [8]. - The company has a robust pipeline of products protected by twenty-one patents, including SPRYNG™ and PrecisePRP, which are currently available for commercial sale [9].